The Hypoxia-Selective Cytotoxin NLCQ-1 (NSC 709257) Controls Metastatic Disease When Used as an Adjuvant to Radiotherapy

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6605753
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The TLR7 Agonist Imiquimod as an Adjuvant for Radiotherapy-Elicited in Situ Vaccination Against Breast Cancer

OncoImmunology
OncologyAllergyImmunology
2013English

TLR9 Agonist, but Not TLR7/8, Functions as an Adjuvant to Diminish FI-RSV Vaccine-Enhanced Disease, While Either Agonist Used as Therapy During Primary RSV Infection Increases Disease Severity

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2009English

Stereotactic Body Radiotherapy in Metastatic Disease: The Known Unknowns and the Unknown Unknowns

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Overcoming Tumor Hypoxia as a Barrier to Radiotherapy, Chemotherapy and Immunotherapy in Cancer Treatment

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2018English

High Mobility Group Box 1 Influences HSV1716 Spread and Acts as an Adjuvant to Chemotherapy

Viruses
VirologyInfectious Diseases
2018English

The RNA-Binding Protein RBM3 Promotes Neural Stem Cell (NSC) Proliferation Under Hypoxia

Frontiers in Cell and Developmental Biology
Developmental BiologyCell Biology
2019English

Hypercalcemia Caused by Metastatic Adamantinoma: Response to Radiotherapy

Sarcoma
Nuclear MedicineRadiologyImagingOncology
1999English

Spironolactone as an Adjuvant to the Treatment of Congestive Cardiac Failure

Postgraduate Medical Journal
Medicine
1964English

Higher Muscle Tissue Oxygenation When Exposed to Hypobaric Hypoxia Than Normobaric Hypoxia

Journal of Human Performance in Extreme Environments
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy